CD64% achieved 92.8% sensitivity and 90.8% specificity, respectively; these results come in line with other reported study results regarding the valuable role of CD64 as an early diagnostic neonatal sepsis marker, especially when combined with other acute phase reactants as CRP measurement [8, 30, 31]. This evidence concerns the gene FCGR1A and Sepsis.